Home/Kintor Pharma/Luke Cheung
LC

Luke Cheung

CFO

Kintor Pharma

Therapeutic Areas

Kintor Pharma Pipeline

DrugIndicationPhase
KX-826Androgenetic Alopecia (AGA)Phase 3
GT20029Acne and AGAPhase 2
GT90001Multiple CancersPhase 2
PyrilutamideAcnePhase 2
GT1709Acute Myeloid LeukemiaPhase 1
Hedgehog InhibitorBasal-cell CarcinomaIND Cleared